Physician profile
Amrish Malhi
NPI 1033395330
$37,325.98
in general payments reported to CMS, 2019-2025
36 companies · $2,467 in 2025
The $2,467 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,058 · 2020: $530 · 2021: $2,491 · 2022: $13K · 2023: $11K · 2024: $6,736 · 2025: $2,467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,753 · Consulting Fee: $7,500 · Travel and Lodging: $4,444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,752.68 |
| Consulting Fee | $7,500.00 |
| Travel and Lodging | $4,444.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $18,197.34 | 2022-2023 | Artis Icono Floor |
| Abbott Laboratories | $5,551.05 | 2020-2024 | Jot Dx, Optis, Amplatzer Amulet |
| Boston Scientific Corporation | $4,513.90 | 2020-2025 | Ekosonic, General - Vascular Access, Avvigo Guidance System |
| Penumbra, INC. | $2,283.50 | 2024 | Indigo System |
| Heartflow, INC. | $817.77 | 2024-2025 | |
| Abiomed | $782.63 | 2021-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $715.41 | 2019-2025 | Lifevest |
| Shockwave Medical, INC | $570.05 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $371.82 | 2019-2024 | Farxiga |
| Janssen Pharmaceuticals, INC | $366.08 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $360.41 | 2019-2025 | |
| Philips North America LLC | $347.89 | 2019-2022 | |
| Medtronic, INC. | $271.52 | 2021-2022 | |
| Pfizer INC. | $239.76 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $225.22 | 2021-2023 | Verquvo |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $201.59 | 2019-2025 | Repatha, Repatha |
| W. L. Gore & Associates, INC. | $192.64 | 2019 | |
| Cvrx, INC. | $161.97 | 2021-2023 | Barostim Neo System |
| Edwards Lifesciences Corporation | $148.38 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $141.56 | 2021-2024 | Camzyos |
| Biotronik INC. | $138.74 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.67 | 2022-2024 | Jardiance |
| Lantheus Medical Imaging, INC. | $122.17 | 2023-2024 | Definity |
| Cleerly, INC. | $55.02 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Stryker Corporation | $54.62 | 2025 | Inthrill Thrombectomy Catheter |
| Chiesi USA, INC. | $50.82 | 2019-2025 | Kengreal |
| Cardiovascular Systems INC. | $48.01 | 2019-2020 | |
| Teleflex LLC | $40.48 | 2025 | Guideliner, Trapliner |
| Lexicon Pharmaceuticals, INC. | $38.64 | 2023 | Inpefa |
| Baxter Healthcare | $33.99 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Kiniksa Pharmaceuticals, Ltd. | $33.21 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $31.84 | 2022 | |
| Imperative Care, INC | $29.52 | 2025 | Symphony Catheter |
| Argon Medical Devices, INC. | $24.57 | 2024 | Clot Management |
| Actelion Pharmaceuticals US, INC. | $21.33 | 2025 | Uptravi, Opsumit |
| Kowa Pharmaceuticals America, INC. | $19.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amrish Malhi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.